Review highlights advances in malaria genomics and vaccine development in Africa, suggesting local research enhances public health outcomes.
Malaria remains one of the most pressing public health challenges in Africa, a continent that bears a significant percentage of the global malaria morbidity and mortality. From the earliest microscopic discoveries of Plasmodium to the era of genomics and vaccine innovations, Africa has stood both as the epicentre of the disease, and the focal point of global research and control efforts. The continent’s unique ecological, genetic, and socio-political contexts have also shaped the evolution of the parasite, the host, and the mosquito vector. African scientists, institutions, and communities have progressively transitioned from being subjects of investigations to active contributors in malaria research; advancing studies in epidemiology, molecular biology, pharmacogenomics, and vaccine development. This review traces the journey of malaria science from its microscopic origins to genomic breakthroughs; emphasising how Africa’s contributions, challenges, and innovations have redefined global understanding. It also highlights the importance of locally-driven research, surveillance, and policy frameworks to translate genomic data into practical solutions, aiming towards equitable and sustainable malaria elimination on the continent.
No takes yet. Share an insight, caveat, or question.
Onaolapo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: